Sort by
Refine Your Search
-
programming. Your work will not only advance the science but also influence real-world applications—from consumer electronics to immersive environments. The position offers the opportunity to: Collaborate with
-
2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a
-
Researcher (R3) Country United Kingdom Application Deadline 30 Oct 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a
-
A position is available in the Faculty of Medicine at the University of Southampton for a Research Fellow to join the REPAIR study, funded by Wellcome Leap as part of the Missed Vital Sign programme
-
must have a PhD in Bioinformatics, Computational Biology, or a closely related field (or be nearing completion of their qualification). You will have demonstrable experience in programming with R and a
-
Application Deadline 21 Oct 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff
-
Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description A position is available in the Faculty of Medicine
-
programming is required. Epidemiological knowledge of pandemics is not required but is helpful. Selected candidates will be interviewed. Two letters of reference sent to the grant holder are also required. What
-
to geotechnical centrifuge modelling. TAILWIND is a multi-disciplinary international research project, funded by the Horizon Europe programme, led by the Norwegian Geotechnical Institute (NGI), in collaboration
-
of Southampton. We are seeking a collaborative and motivated postdoctoral scientist to work on our Blood Cancer UK-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid